Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00985257 · ClinicalTrials.gov registry record · NA

Performance of a New Glucose Meter System in Children and Young Adults

A NA study of Diabetes, sponsored by Ascensia Diabetes Care.

Completed
Registry status
NA
Development phase
123
Enrollment target
2
Study locations

NCT00985257 is a NA study of Diabetes that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 123 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00985257, a NA study of Diabetes, has completed, sponsored by Ascensia Diabetes Care.

COMPLETED
Registry status
NA
Development phase
123 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to evaluate the performance of a new blood glucose meter in the hands of children, teens, young adults.

Conditions Studied

Interventions

  • DEVICE DIDGET (Investigational Blood Glucose Monitoring System)

Study Locations (2)

California

  • AMCR Institute - Escondido

Florida

  • Larry C. Deeb, MD PA - Tallahassee

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2009-09
Est. Completion 2009-10
Phase NA

Sponsor

Ascensia Diabetes Care

42 total trials

What the Registry Record Tells You About NCT00985257

The ClinicalTrials.gov registry entry for NCT00985257 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which DIDGET (Investigational Blood Glucose Monitoring System) is the first listed.

NCT00985257 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Florida.

Frequently Asked Questions

What is clinical trial NCT00985257 about?

NCT00985257 is a clinical study titled "Performance of a New Glucose Meter System in Children and Young Adults". The purpose of this study is to evaluate the performance of a new blood glucose meter in the hands of children, teens, young adults.

What is the current status of trial NCT00985257?

This trial is currently completed. It is a NA study. The enrollment target is 123 participants. The study started on 2009-09. Estimated completion is 2009-10.

What conditions does trial NCT00985257 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT00985257?

The interventions under investigation include: DIDGET (Investigational Blood Glucose Monitoring System) (DEVICE).

Who is sponsoring clinical trial NCT00985257?

This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00985257 being conducted?

This trial has 2 study locations across California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.